HDAC-IN-39 is a potent HDAC inhibitor with IC50 values of 1.07 μM (HDAC1), 1.47 μM (HDAC2), and 2.27 μM (HDAC3); it also significantly inhibits microtubule polymerization, induces G2/M phase cell cycle arrest, and exhibits potent anticancer activity against drug-resistant cancer cells.